Combining radiation with immunotherapy showing promise against melanoma

May 19, 2016, Loyola University Health System
Melanoma in skin biopsy with H&E stain — this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0

Combining radiation treatments with a new generation of immunotherapies is showing promise as a one-two-punch against melanoma, Loyola Medicine researchers report in the Journal of Radiation Oncology.

Radiation kills by damaging their DNA. Immunotherapies work by harnessing a patient's immune system to attack and kill cancer cells. When combined, the two therapies appear to have synergistic effects, according to the article by James S. Welsh, MD and colleagues.

Dr. Welsh is a professor in the department of oncology of Loyola University Chicago Stritch School of Medicine.

Melanoma is one of the most aggressive forms of skin cancer. Among patients with Stage 4 metastatic , in which the cancer has spread to other organs, one-year survival rates range from just 33 percent to 62 percent. This year in the United States, about 76,000 patients will be diagnosed with melanoma and about 10,000 people are expected to die of the disease, according to the American Cancer Society.

On rare occasions, melanoma patients can spontaneously go into remission. More common are partial spontaneous regressions of melanoma lesions. While scientists aren't certain what causes these effects, evidence points to the immune system mounting an attack on cancer cells.

A key observation that supports the role of the immune system in melanoma is the abscopal effect.This rare phenomenon occurs when a localized treatment such as radiation not only shrinks the targeted tumor but also stimulates the immune system to mount a systemic attack on cancer cells throughout the body. Dr. Welsh saw the abscopal effect firsthand when he gave radiation treatment to a patient who had melanoma that had spread to his liver and bones.The radiation was intended merely to shrink a tumor in the patient's thigh bone, to relieve his pain and reduce the risk of fracture. But three months later, a CT scan found no trace of cancer anywhere.

Many new immunotherapies for melanoma are being tried, some with notable results. One such example is a of "checkpoint inhibitors." These are drugs that, in effect, remove the brakes that normally prevent the immune system from attacking cancer cells.

Radiation increasingly is being used alongside checkpoint inhibitors and other immunotherapies, with encouraging results, Dr. Welsh and colleagues write.

Despite the recent successes of radiation and immunotherapy, not all are able to mount an effective response to fight melanoma. So it is important to discover proteins or other biomarkers that can predict whether a patient will respond to immunotherapy. Such biomarkers also could help quantify how well experimental therapies are working, Dr. Welsh and colleagues write.

The review article article summarizes the latest research in how radiation can be integrated with immunotherapy in the treatment of melanoma. It is titled "The integration of radiation therapy and immunotherapy in melanoma management."

Explore further: Why 'sharks get cancer, mole rats don't'

More information: Kyle Stang et al, The integration of radiation therapy and immunotherapy in melanoma management, Journal of Radiation Oncology (2016). DOI: 10.1007/s13566-016-0256-5

Related Stories

Why 'sharks get cancer, mole rats don't'

May 6, 2016
A provocative new book by Loyola Medicine radiation oncologist James S. Welsh, MD, Sharks Get Cancer, Mole Rats Don't: How Animals Could Hold the Key to Unlocking Cancer Immunity in Humans, explores how animals can help us ...

Long-term survival achieved in metastatic melanoma with personalized vaccine

May 10, 2016
Two patients with melanoma that had spread to the liver survived for at least 8.5 and 12 years after resection of the hepatic tumor and treatment with patient-specific immunotherapeutic vaccines. The vaccines, designed to ...

Radiation combined with immune-stimulating drugs could pack a powerful punch against cancer cells

March 21, 2016
In his final State of the Union address, President Obama tasked Vice President Joe Biden with leading a new National Cancer Moonshot initiative. The hope is that this will put America on course to be "the country that cures ...

Researchers discover how immune cells resist radiation treatment

November 24, 2015
Researchers at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai have discovered a key mechanism by which radiation treatment (radiotherapy) fails to completely destroy tumors. And, in the journal ...

Protein may predict response to immunotherapy in patients with metastatic melanoma

May 5, 2016
A protein called Bim may hold the clue to which patients may be successful on immunotherapy for metastatic melanoma, according to the results of a study by Mayo Clinic researchers led by senior author Haidong Dong, M.D., ...

Systemic tumor disappearance following local radiation treatment reported in metastatic melanoma patient

March 7, 2012
A rarely seen phenomenon in cancer patients — in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body — has been reported in a patient with ...

Recommended for you

Study shows how to make (and destroy) a metastatic cancer cell

August 20, 2018
Many cancers become especially dangerous only when they metastasize from their site of origin to faraway tissues such as lung, brain or bone. Now, a University of Colorado Cancer Center study published today in the Proceedings ...

Research team develops predictor for immunotherapy response in melanoma

August 20, 2018
In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors, a novel type of immunotherapy. ...

Study details effect of radiation exposure on hormone deficiencies

August 20, 2018
In a new study, University of Cincinnati (UC) researchers, in collaboration with Massachusetts General Hospital, have detailed the effect of radiation exposure on the development of hormone deficiency in pediatric and young ...

Scientists discover new method of diagnosing cancer with malaria protein

August 17, 2018
In a spectacular new study, researchers from the University of Copenhagen have discovered a method of diagnosing a broad range of cancers at their early stages by utilising a particular malaria protein that sticks to cancer ...

Researchers find pathways that uncover insight into development of lung cancer

August 17, 2018
Lung cancer is the leading cause of preventable cancer death. A disease of complex origin, lung cancer is usually considered to result from effects of smoking and from multiple genetic variants. One of these genetic components, ...

Developing an on-off switch for breast cancer treatment

August 17, 2018
T-cells play an important role in the body's immune system, and one of their tasks is to find and destroy infection. However, T-cells struggle to identify solid, cancerous tumors in the body. A current cancer therapy is using ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.